Oriol Dols‐Icardo

7.0k total citations · 1 hit paper
40 papers, 1.2k citations indexed

About

Oriol Dols‐Icardo is a scholar working on Neurology, Physiology and Molecular Biology. According to data from OpenAlex, Oriol Dols‐Icardo has authored 40 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Neurology, 21 papers in Physiology and 10 papers in Molecular Biology. Recurrent topics in Oriol Dols‐Icardo's work include Alzheimer's disease research and treatments (20 papers), Amyotrophic Lateral Sclerosis Research (15 papers) and Parkinson's Disease Mechanisms and Treatments (10 papers). Oriol Dols‐Icardo is often cited by papers focused on Alzheimer's disease research and treatments (20 papers), Amyotrophic Lateral Sclerosis Research (15 papers) and Parkinson's Disease Mechanisms and Treatments (10 papers). Oriol Dols‐Icardo collaborates with scholars based in Spain, United States and Austria. Oriol Dols‐Icardo's co-authors include Alberto Lleó, Jordi Clarimón, Daniel Alcolea, Rafael Blesa, Juan Fortea, Marc Suárez‐Calvet, Laia Muñoz, Teresa Gómez‐Isla, Marta Marquié and Víctor Montal and has published in prestigious journals such as Nature Medicine, PLoS ONE and Brain.

In The Last Decade

Oriol Dols‐Icardo

38 papers receiving 1.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

APOE4 homozygosity represents a distinct genetic form of Alzheimer’s disease

2024 140 citations Juan Fortea, Jordi Pegueroles et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Oriol Dols‐Icardo Spain	16	700	564	335	323	221	40	1.2k
Omi Katsuse Japan	27	949 1.4×	1.1k 2.0×	428 1.3×	338 1.0×	251 1.1×	55	1.9k
Gina Bisceglio United States	17	813 1.2×	503 0.9×	253 0.8×	602 1.9×	178 0.8×	25	1.5k
Tatsuhiro Terada Japan	20	332 0.5×	326 0.6×	354 1.1×	332 1.0×	216 1.0×	55	1.2k
Ivan Milenković Austria	22	537 0.8×	394 0.7×	287 0.9×	573 1.8×	477 2.2×	49	1.6k
Daniel Erskine United Kingdom	20	604 0.9×	758 1.3×	338 1.0×	312 1.0×	262 1.2×	47	1.4k
Naomi Kouri United States	16	671 1.0×	686 1.2×	326 1.0×	262 0.8×	234 1.1×	31	1.2k
Masakuni Amari Japan	15	503 0.7×	431 0.8×	207 0.6×	275 0.9×	123 0.6×	45	1.0k
Miles C. Miller United States	18	872 1.2×	219 0.4×	486 1.5×	435 1.3×	349 1.6×	34	1.6k
Olivia Belbin Spain	18	875 1.3×	248 0.4×	264 0.8×	550 1.7×	174 0.8×	51	1.4k
Dawn H. W. Lau United Kingdom	13	780 1.1×	373 0.7×	254 0.8×	865 2.7×	459 2.1×	14	1.6k

Countries citing papers authored by Oriol Dols‐Icardo

Since Specialization

Citations

This map shows the geographic impact of Oriol Dols‐Icardo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oriol Dols‐Icardo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oriol Dols‐Icardo more than expected).

Fields of papers citing papers by Oriol Dols‐Icardo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oriol Dols‐Icardo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oriol Dols‐Icardo. The network helps show where Oriol Dols‐Icardo may publish in the future.

Co-authorship network of co-authors of Oriol Dols‐Icardo

This figure shows the co-authorship network connecting the top 25 collaborators of Oriol Dols‐Icardo. A scholar is included among the top collaborators of Oriol Dols‐Icardo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oriol Dols‐Icardo. Oriol Dols‐Icardo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rubio‐Guerra, Sara, Sara Bernal, Valle Camacho, et al.. (2025). A Novel CHMP2B Splicing Variant in Atypical Presentation of Familial Frontotemporal Lobar Degeneration. Annals of Clinical and Translational Neurology. 12(9). 1894–1900. 1 indexed citations

Fortea, Juan, Jordi Pegueroles, Daniel Alcolea, et al.. (2024). APOE4 homozygosity represents a distinct genetic form of Alzheimer’s disease. Nature Medicine. 30(5). 1284–1291. 140 indexed citations breakdown →

Núñez‐Llaves, Raúl, et al.. (2024). Synapse‐enriched miRNA expression in Alzheimer’s disease cortex tissue. Alzheimer s & Dementia. 20(S1). e090741–e090741. 1 indexed citations

Álvarez‐Velasco, Rodrigo, Oriol Dols‐Icardo, Laura López-Vilaró, et al.. (2023). Reduced Number of Thymoma CTLA4-Positive Cells Is Associated With a Higher Probability of Developing Myasthenia Gravis. Neurology Neuroimmunology & Neuroinflammation. 10(2). 4 indexed citations

Dols‐Icardo, Oriol, Sebastiaan Engelborghs, Bart Buelens, et al.. (2023). Proteomic comparison between non‐purified cerebrospinal fluid and cerebrospinal fluid‐derived extracellular vesicles from patients with Alzheimer's, Parkinson's and Lewy body dementia. Journal of Extracellular Vesicles. 12(12). e12383–e12383. 14 indexed citations

Querol‐Vilaseca, Marta, Raúl Núñez‐Llaves, Jordi Pegueroles, et al.. (2023). Amyloid precursor protein 𝛽CTF accumulates in synapses in sporadic and genetic forms of Alzheimer's disease. Neuropathology and Applied Neurobiology. 49(1). e12879–e12879. 5 indexed citations

Montal, Víctor, Ibai Díez, Chan Mi Kim, et al.. (2022). Network Tau spreading is vulnerable to the expression gradients of APOE and glutamatergic-related genes. Science Translational Medicine. 14(655). eabn7273–eabn7273. 28 indexed citations

Reyes‐Leiva, David, Oriol Dols‐Icardo, Sònia Sirisi, et al.. (2022). Pathophysiological Underpinnings of Extra-Motor Neurodegeneration in Amyotrophic Lateral Sclerosis: New Insights From Biomarker Studies. Frontiers in Neurology. 12. 750543–750543. 10 indexed citations

Irwin, David J., Daniel Alcolea, Corey T. McMillan, et al.. (2022). Multimarker synaptic protein cerebrospinal fluid panels reflect TDP-43 pathology and cognitive performance in a pathological cohort of frontotemporal lobar degeneration. Molecular Neurodegeneration. 17(1). 29–29. 9 indexed citations

10.

Dols‐Icardo, Oriol, Víctor Montal, Sònia Sirisi, et al.. (2020). Motor cortex transcriptome reveals microglial key events in amyotrophic lateral sclerosis. Neurology Neuroimmunology & Neuroinflammation. 7(5). 57 indexed citations

11.

Cervera‐Carles, Laura, Oriol Dols‐Icardo, Laura Molina‐Porcel, et al.. (2020). Assessing circular RNAs in Alzheimer's disease and frontotemporal lobar degeneration. Neurobiology of Aging. 92. 7–11. 36 indexed citations

12.

Berthier, Marcelo L., Guadalupe Dávila, Jordi Clarimón, et al.. (2020). Developmental Dynamic Dysphasia: Are Bilateral Brain Abnormalities a Signature of Inefficient Neural Plasticity?. Frontiers in Human Neuroscience. 14. 73–73. 7 indexed citations

13.

Clarimón, Jordi, Sonia Moreno–Grau, Laura Cervera‐Carles, et al.. (2020). Genetic architecture of neurodegenerative dementias. Neuropharmacology. 168. 108014–108014. 6 indexed citations

14.

Aguilar, L., Cinta Lleixà, Andrea Cortese, et al.. (2019). Absence of pathogenic mutations in CD59 in chronic inflammatory demyelinating polyradiculoneuropathy. PLoS ONE. 14(2). e0212647–e0212647. 2 indexed citations

15.

Menéndez‐González, Manuel, Jordi Clarimón, Marta Blázquez Estrada, et al.. (2018). HTT gene intermediate alleles in neurodegeneration: evidence for association with Alzheimer's disease. Neurobiology of Aging. 76. 215.e9–215.e14. 15 indexed citations

16.

Suárez‐Calvet, Marc, Valle Camacho, Beatriz Gómez‐Ansón, et al.. (2014). Early Cerebellar Hypometabolism in Patients With Frontotemporal Dementia Carrying the C9orf72 Expansion. Alzheimer Disease & Associated Disorders. 29(4). 353–356. 6 indexed citations

17.

Suárez‐Calvet, Marc, Oriol Dols‐Icardo, Albert Lladó, et al.. (2013). Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation. Journal of Neurology Neurosurgery & Psychiatry. 85(6). 684–691. 59 indexed citations

18.

Dols‐Icardo, Oriol, Marc Suárez‐Calvet, Isabel de la Torre Díez, et al.. (2012). Expansion mutation in C9ORF72 does not influence plasma progranulin levels in frontotemporal dementia. Neurobiology of Aging. 33(8). 1851.e17–1851.e19. 11 indexed citations

19.

Colom‐Cadena, Martí, Ellen Gelpí, María José Martí, et al.. (2012). MAPT H1 haplotype is associated with enhanced α-synuclein deposition in dementia with Lewy bodies. Neurobiology of Aging. 34(3). 936–942. 43 indexed citations

20.

Setó‐Salvia, Núria, Jordi Clarimón, Javier Pagonabarraga, et al.. (2011). Dementia Risk in Parkinson Disease. Archives of Neurology. 68(3). 359–64. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact